title: Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases.
abstract: Many existing therapies in autoimmune diseases are based on systemic suppression of inflammation and the observed side effects of these therapies illustrate the pressing need for more specific interventions. Regulatory T-cells (Treg) are pivotal controllers of (auto-aggressive) immune responses and inflammation, and decreased Treg numbers and/or functioning have been associated with autoimmune disease. Therefore, Treg became frequently studied targets for more specific immunotherapy. Especially antigen-specific targeting of Treg would enable local and tailor made interventions, while obviating the negative side effect of general immuno-suppression. Self-antigens that participate in inflammation, irrespective of the etiology of the different autoimmune diseases, are held to be candidate antigens for antigen-specific interventions. Rather than tolerance induction to disease inciting self-antigens, which are frequently unknown, general self-antigens expressed at sites of inflammation would allow targeting of disease independent, but inflammatory-site specific, regulatory mechanisms. Preferably, such self-antigens should be abundantly expressed and up-regulated at the inflammatory-site. In this perspective heat shock proteins (Hsp) have several characteristics that make them highly attractive targets for antigen-specific Treg inducing therapy. The development of an antigen-specific Treg inducing vaccine is a major novel goal in the field of immunotherapy in autoimmune diseases. However, progress is hampered not only by the lack of effective antigens, but also by the fact that other factors such as dose, route, and the presence or absence of an adjuvant, turned out to be critical unknowns, with respect to the effective induction of Treg. In addition, the use of a Treg inducing adjuvant might be required to achieve an effective regulatory response, in the case of ongoing inflammation. Future goals in clinical trials will be the optimization of natural Treg expansion (or the induction of adaptive Treg) without loss of their suppressive function or the concomitant induction of non-regulatory T-cells. Here, we will discuss the potential use of protein/peptide-based vaccines combined with Treg inducing adjuvants for the development of therapeutic vaccines against chronic inflammatory conditions.
authors: Immunology, Infectious Diseases and Immunology, Faculty Veterinary Medicine, University Utrecht , Utrecht , Netherlands.
authors: Chantal
authors: C
authors: Keijzer
authors: Ruurd
authors: R
authors: van der Zee
authors: Willem
authors: W
authors: van Eden
authors: Femke
authors: F
authors: Broere
keywords: Treg inducing adjuvants; autoimmunity; immunologic adjuvants; regulatory T-cells; therapeutic vaccines
references: J Autoimmun. 2009 Sep;33(2):135-40
references: 19625166
references: Arterioscler Thromb Vasc Biol. 2010 May;30(5):946-52
references: 20167655
references: Immunity. 2011 Jul 22;35(1):13-22
references: 21777796
references: J Immunol. 2011 Sep 1;187(5):2278-90
references: 21775683
references: PLoS One. 2013;8(2):e55307
references: 23393567
references: Nat Rev Immunol. 2008 Jul;8(7):523-32
references: 18566595
references: Diabetes. 1999 Nov;48(11):2150-6
references: 10535448
references: Transpl Immunol. 2012 Aug;27(1):30-8
references: 22613676
references: J Mol Biol. 1965 Aug;13(1):238-52
references: 5859039
references: Diabetes Metab Res Rev. 2007 May;23(4):292-8
references: 17124720
references: J Immunol. 2012 Sep 1;189(5):2512-20
references: 22844110
references: PLoS One. 2011;6(8):e23453
references: 21858123
references: J Biol Chem. 2002 Dec 13;277(50):48122-9
references: 12359728
references: Clin Exp Immunol. 2010 Apr;160(1):70-9
references: 20415854
references: Diabetes. 2009 Jan;58(1):146-55
references: 18984738
references: Virology. 2008 Oct 25;380(2):412-20
references: 18786689
references: Biochem Biophys Res Commun. 2010 Mar 26;394(1):228-32
references: 20206130
references: J Clin Invest. 2006 Apr;116(4):916-28
references: 16543948
references: Nat Biotechnol. 2012 Feb 08;30(2):124
references: 22318018
references: J Exp Med. 2012 Jul 30;209(8):1437-44
references: 22778390
references: J Gastroenterol. 2012 Apr;47(4):366-76
references: 22189601
references: Vaccine. 2003 Apr 2;21(15):1687-93
references: 12639491
references: Circ Res. 2009 Jun 19;104(12):e62-70
references: 19478203
references: J Autoimmun. 2010 Mar;34(2):111-20
references: 19665867
references: J Immunol. 1997 Apr 15;158(8):3936-46
references: 9103464
references: J Immunol. 2009 May 15;182(10):6071-8
references: 19414758
references: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4228-33
references: 15024101
references: J Immunol. 2008 Apr 15;180(8):5211-21
references: 18390702
references: Arthritis Rheum. 2009 Nov;60(11):3207-16
references: 19877047
references: Diabetes. 2008 Sep;57(9):2341-7
references: 18559659
references: Clin Immunol. 2011 Jan;138(1):117-26
references: 21044870
references: J Immunol. 2012 Jul 15;189(2):1062-71
references: 22696440
references: Microbiol Immunol. 2008 Feb;52(2):55-63
references: 18380802
references: Mol Immunol. 2012 Jun;51(2):210-8
references: 22482518
references: Nat Rev Immunol. 2005 Apr;5(4):318-30
references: 15803151
references: J Immunol. 2005 Jun 15;174(12):7558-63
references: 15944255
references: N Engl J Med. 2004 Feb 26;350(9):860-1
references: 14985482
references: Int J Cancer. 2012 Jul 1;131(1):106-16
references: 21858807
references: Eur J Immunol. 2010 Jun;40(6):1682-96
references: 20306466
references: J Immunol. 2000 Jan 1;164(1):183-90
references: 10605010
references: Blood. 2005 Jun 15;105(12):4743-8
references: 15746082
references: J Clin Invest. 2013 Apr;123(4):1677-93
references: 23478407
references: Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16246-51
references: 20805478
references: BMJ. 1989 Nov 18;299(6710):1259-60
references: 2513902
references: J Immunol. 2008 Dec 15;181(12):8278-87
references: 19050244
references: FEMS Immunol Med Microbiol. 2006 Oct;48(1):44-55
references: 16965351
references: Semin Immunol. 2009 Feb;21(1):22-7
references: 18778953
references: Int Immunol. 2008 Apr;20(4):471-83
references: 18272926
references: Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2677-83
references: 17901374
references: PLoS One. 2010 Dec 08;5(12):e14264
references: 21170379
references: Diabetologia. 2010 Sep;53(9):1958-70
references: 20490452
references: Nat Rev Immunol. 2004 Jan;4(1):24-34
references: 14704765
references: J Immunol. 2003 Nov 1;171(9):4592-603
references: 14568933
references: Immunity. 2009 May;30(5):636-45
references: 19464986
references: N Engl J Med. 2004 Feb 26;350(9):896-903
references: 14985487
references: Arthritis Rheum. 2002 Apr;46(4):1109-20
references: 11953991
references: Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1021-31
references: 21244752
references: PLoS One. 2006 Dec 20;1:e87
references: 17183718
references: Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):21-42
references: 11516777
references: Comp Immunol Microbiol Infect Dis. 2011 Sep;34(5):429-39
references: 21903269
references: Science. 1994 Aug 26;265(5176):1237-40
references: 7520605
references: Parasite Immunol. 2006 Oct;28(10):515-23
references: 16965287
references: Vaccine. 2006 Mar 10;24(11):1847-57
references: 16288821
references: Parasite Immunol. 2009 Oct;31(10):641-5
references: 19751476
references: Curr Opin Pharmacol. 2004 Aug;4(4):403-7
references: 15251136
references: J Clin Invest. 2006 May;116(5):1371-81
references: 16628253
references: J Immunol. 2009 Mar 15;182(6):3556-65
references: 19265134
references: Nat Biotechnol. 2012 Dec;30(12):1217-24
references: 23159881
references: J Clin Invest. 2006 Feb;116(2):485-94
references: 16424940
references: Scand J Immunol. 1997 Nov;46(5):506-13
references: 9393634
references: J Neuroimmunol. 2010 Mar 30;220(1-2):52-63
references: 20149931
references: PLoS One. 2011;6(11):e26684
references: 22073184
references: Parasite Immunol. 2012 Apr;34(4):210-23
references: 22224925
references: Circulation. 2006 Oct 31;114(18):1977-84
references: 17043169
references: Arthritis Rheum. 2012 Oct;64(10):3168-78
references: 22729944
references: Nat Med. 2003 Sep;9(9):1202-8
references: 12937416
references: Cell Host Microbe. 2008 Oct 16;4(4):350-61
references: 18854239
references: J Gene Med. 2009 Nov;11(11):1064-70
references: 19688809
references: J Immunol. 2006 Dec 15;177(12):8338-47
references: 17142730
references: Nat Protoc. 2006;1(2):653-61
references: 17802642
references: J Cell Sci. 2013 Apr 15;126(Pt 8):1713-9
references: 23641065
references: Expert Opin Biol Ther. 2011 Sep;11(9):1233-40
references: 21751937
references: J Control Release. 2013 May 28;168(1):35-40
references: 23500056
references: Trends Immunol. 2008 Sep;29(9):429-35
references: 18676178
references: Eur J Immunol. 2007 Nov;37 Suppl 1:S116-23
references: 17972355
references: Lancet. 2001 Nov 24;358(9295):1749-53
references: 11734230
references: Gut. 2009 Oct;58(10):1363-73
references: 19505881
references: J Immunol. 2010 Mar 15;184(6):2776-84
references: 20142362